2
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Serum from endometriosis patients impairs the development of mouse embryos in vitro — comparison with serum from tubal obstruction patient and plasmanate

, &
Pages 877-880 | Received 27 Dec 1995, Accepted 08 May 1996, Published online: 03 Aug 2009
 

Abstract

Background. The aim of this study was to evaluate the inhibitory effect of serum from endometriosis. To determine the effects of serum obtained from patients with endometriosis on mouse embryo development, we compared the fertilization and cleavage rates of mouse embryo in a standard mouse embryo culture system.

Methods. Sera were collected from 13 individuals who were diagnosed endometriosis and ten individuals who were diagnosed as having tubal obstruction. Mouse embryos were fertilized and cultured in vitro with serum supplement obtained from patients with endometriosis (n= 13) and tubal obstruction (n=10), and plasmanate (n=10).

Results. The fertilization rate was 26.6±14.9% in patients serum with endometriosis, and the cleavage rate was 21.2±9.1%, respectively. However, the fertilization rates were 60.9±12.5% (tubal obstruction group), and 77.3±14.7% (plasmanate group), the cleavage rates were 32.2±16.4% and 36.2±9.9%, respectively.

Conclusions. Serum from patients with endometriosis revealed toxic effects on mouse embryos in vitro. The use of plasmanate instead of whole serum from patients with endometriosis will hopefully bring a better understanding of embryo development.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.